Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Munsch FrederickSVP, Controller and CAO |  BLCOBausch & Lomb CorpOption exercise | M | — 87.9K sh | Nov 2, 2026 |
| 5 | Delco Albert BradEVP & CFO |  JBHTHUNT J B TRANSPORT SERVICES INCOption exercise | M | — 235 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Billings William G.Chief Accounting Officer |  CHWYChewy, Inc.Tax withholding | F | $22K 1,064 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 5 | Sayad Pierre SargisChief Medical Officer |  FENCFENNEC PHARMACEUTICALS INC.Grant or award | A | — 168 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $27K 124 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Munsch FrederickSVP, Controller and CAO | BLCOBausch & Lomb Corp Option exercise | M | — 24.1K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 237 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $23K 103 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $33K 151 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Singh SumitDirector, Chief Executive Officer | CHWYChewy, Inc. Tax withholding | F | $45K 2,172 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 5 | Hershkowitz StevenEVP & Chief Revenue Officer |  RMNIRimini Street, Inc.Option exercise | M | $32K 9,149 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 237 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Hershkowitz StevenEVP & Chief Revenue Officer | RMNIRimini Street, Inc. Option exercise | M | — 9,149 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 5 | Hershkowitz StevenEVP & Chief Revenue Officer | RMNIRimini Street, Inc. Option exercise | M | — 33.3K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 5 | Woodruff Ronald GreerEVP Safety, ESG, Maintenance | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 230 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Bertolini JeffreyChief Operating Officer |  CARLCARLSMED, INC.Open-market sale · 10b5-1 plan | SELL | $3,839 243 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 5 | Woodruff Ronald GreerEVP Safety, ESG, Maintenance | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $21K 96 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Grant or award | A | — 100.0K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 5 | Wolf Kurt JamesDirector, President & CEO |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $219K 13.5K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 286 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 350 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $43K 546 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Hansen GwennChief Scientific Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Hyman JonathanChief Technology Officer |  BRZEBraze, Inc.Open-market sale · 10b5-1 plan | SELL | $915K 20.0K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 1 | Canning Susan M.SVP, CLO, Corporate Secretary |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $40K 2,500 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 1 | Canning Susan M.SVP, CLO, Corporate Secretary | HAYWHayward Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 2,000 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 546 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 263 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $44K 262 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K